- Home
- MDAIW vs ICFI Comparison
MDAIW vs ICFI Comparison
Compare MDAIW & ICFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAIW
- ICFI
- Stock Information
- Founded
- MDAIW N/A
- ICFI 1969
- Country
- MDAIW United States
- ICFI United States
- Employees
- MDAIW 78
- ICFI N/A
- Industry
- MDAIW Medical/Dental Instruments
- ICFI Professional Services
- Sector
- MDAIW Health Care
- ICFI Consumer Discretionary
- Exchange
- MDAIW Nasdaq
- ICFI Nasdaq
- Market Cap
- MDAIW N/A
- ICFI N/A
- IPO Year
- MDAIW 2021
- ICFI 2006
- Fundamental
- Price
- MDAIW $0.13
- ICFI $134.35
- Analyst Decision
- MDAIW
- ICFI Strong Buy
- Analyst Count
- MDAIW 0
- ICFI 4
- Target Price
- MDAIW N/A
- ICFI $167.25
- AVG Volume (30 Days)
- MDAIW N/A
- ICFI 235.4K
- Earning Date
- MDAIW N/A
- ICFI 10-31-2024
- Dividend Yield
- MDAIW N/A
- ICFI 0.42%
- EPS Growth
- MDAIW N/A
- ICFI 55.44
- EPS
- MDAIW N/A
- ICFI 5.69
- Revenue
- MDAIW N/A
- ICFI $2,001,815,000.00
- Revenue This Year
- MDAIW N/A
- ICFI $5.34
- Revenue Next Year
- MDAIW N/A
- ICFI $7.54
- P/E Ratio
- MDAIW N/A
- ICFI $23.61
- Revenue Growth
- MDAIW N/A
- ICFI 2.11
- 52 Week Low
- MDAIW N/A
- ICFI $128.28
- 52 Week High
- MDAIW N/A
- ICFI $179.67
- Technical
- Relative Strength Index (RSI)
- MDAIW N/A
- ICFI 24.27
- Support Level
- MDAIW N/A
- ICFI $133.79
- Resistance Level
- MDAIW N/A
- ICFI $138.55
- Average True Range (ATR)
- MDAIW 0.00
- ICFI 6.80
- MACD
- MDAIW 0.00
- ICFI -3.12
- Stochastic Oscillator
- MDAIW 0.00
- ICFI 6.13
About MDAIW Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.